Form 4: Zomedica COO Tony Blair Reports Transaction in Company Stock
SEC Form 4 Filing
Zomedica's COO, Tony Blair, reports the acquisition and disposal of company stock on March 17, 2025.
Summary
- On March 17, 2025, Tony Blair, the COO of Zomedica Corp., filed a Form 4 to report changes in beneficial ownership of the company's stock.
- Blair acquired 500,000 shares of common stock at a price of $0.06 per share.
- Simultaneously, Blair disposed of 900,000 shares of common stock.
- Following these transactions, Blair's beneficially owned securities amount is not explicitly stated in the provided information.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a transaction by an insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of stock acquisition and disposal by Tony Blair, COO of Zomedica Corp. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.